Stifel Financial Corp (SF) Stock Analysis

76.0/100
Buy Not Halal Financial Services
Price $72.75
Market Cap $10.86B
52-Week Change -10.58%

Is SF a good investment?

Stifel Financial Corp (SF) has a Plutrex AI rating of 76.0/100 as of November 09, 2026, indicating a Buy consensus. The stock is not classified as halal-compliant. Key strength: Extreme valuation discount with margin of safety: P/E of 12.37x is 14.7% below peer average (14.50x), PEG of 0.87 is below both the absolute 1.0 threshold and the peer average of 0.97 — at PEG=1.0 fair value, intrinsic value approaches $82-86/share vs. current $71.35, implying 15-20% upside even on conservative assumptions, with more aggressive DCF (applying 18-20x P/E for the quality profile) suggesting $103-126/share. Main concern: Revenue growth collapse remains the defining thesis risk: -0.2% revenue growth vs. industry +16.1% is UNCHANGED from the prior report — the gap has not narrowed, and EPS growth outpacing revenue by ~19 percentage points is driven by buybacks and margin expansion, which have finite runway; if revenue does not inflect positive within 2-4 quarters, the 14.2% 5-year EPS growth projection becomes mathematically implausible and the valuation case weakens materially.

Investment Summary

Stifel Financial (SF) remains a Buy at current levels ($71.35), though the stock has appreciated 7.0% since our prior report ($66.68 → $71.35), narrowing but not eliminating the margin of safety. The core thesis remains intact: P/E of 12.37x is 14.7% below the peer average of 14.50x, PEG of 0.87 (vs. peer 0.97) confirms growth-adjusted undervaluation, and the balance sheet is fortress-grade with D/E of 0.24 vs. industry average of 2.44 and $4.92B in cash. The critical concern — revenue growth of -0.2% vs. industry +16.1% — is UNCHANGED, keeping conviction at Medium. However, news sentiment has remained exceptional at 96.8/100 (10 positive, 0 negative headlines), Q3 EPS grew 14.8% YoY ($1.40 vs. $1.22), loan book expanded $1.3B in Q3, and geographic expansion via KBW's European platform is a nascent catalyst. The price appreciation has pushed PEG from 0.77 to 0.87 — still below 1.0 but meaningfully less compelling. Entry range is adjusted upward to $68.00-$72.00 (from $63.50-$67.50) to reflect the new price level while still seeking a modest discount for the revenue growth risk.

Key Strengths

Key Concerns

Plutrex 10-Factor AI Breakdown

Financial Health
82/100
Growth Potential
62/100
Valuation
82/100
Profitability
83/100
Debt Management
85/100
Analyst Sentiment
62/100
Technical Momentum
60/100
Insider Confidence
65/100
News Sentiment
90/100

Fundamental Analysis

SF's fundamentals reflect a bifurcated story of exceptional quality with a glaring growth deficiency. Profitability: Gross margin of 87.6% (vs. industry 30.7%) signals an asset-light, service-driven model with extraordinary pricing power — this is a 185% premium to peers. Operating margin of 22.5% falls 15.9% below the industry average of 26.75%, indicating the gross margin advantage is consumed by a heavy SG&A/R&D cost structure. Net margin of 14.0% exceeds the industry average of 10.1% by 38.9%, confirming superior bottom-line conversion. ROE of 16.6% matches the industry average of 16.4% despite using only 1/10th the leverage (D/E 0.24 vs. 2.44) — this is genuine operational excellence. Valuation: P/E of 12.37x is 14.7% below the peer average of 14.50x. PEG of 0.87 is below both 1.0 (absolute undervaluation threshold) and the peer average of 0.97. For a business with 87.6% gross margins and $4.92B in cash, this multiple is anomalously cheap. Financial Health: D/E of 0.24 vs. industry 2.44 (90% lower leverage), FCF of $849.5M annually, and $4.92B cash provide a multi-year buffer against revenue weakness. Growth: This is the thesis risk — revenue growth of -0.2% vs. industry +16.1% (101% underperformance), historical earnings growth of 14.8% vs. peer 23.2%, and 5-year forward EPS growth of 14.19% vs. peer 17.10%. EPS growth outpacing revenue growth by 19.6 percentage points is driven by buybacks/margin expansion — a finite and less durable growth driver.

News Sentiment

Stifel Financial is quietly executing while skeptics look elsewhere. The St. Louis-based investment bank reported a strong third quarter, with diluted earnings per share jumping to $1.40 — up 14.8% from $1.22 a year ago — beating Wall Street estimates and demonstrating that the firm's cost discipline is producing real results even as overall revenue stays stubbornly flat. Behind the numbers, Stifel is making strategic moves that could change that revenue story. The company expanded its loan book by $1.3 billion during Q3, putting its massive $4.92 billion cash cushion to work. Meanwhile, through its KBW investment banking platform, Stifel appointed Mark Tweedie as Head of European Investment Banking — a signal that the firm is pushing beyond its U.S. heartland to capture international deal flow. Add three senior hires in Capital Solutions, and you have a management team actively building the revenue engine rather than waiting for the market to come to them. Stifel also declared its quarterly dividend of $0.34 per share — steady cash returns to shareholders while the growth story develops. The company's balance sheet remains one of the strongest in its peer group, with debt-to-equity of just 0.24 compared to an industry average of 2.44, giving it unusual resilience in a sector where leverage is the norm. The bottom line: Stifel is a profitable, conservatively financed bank trading at a discount, quietly expanding while generating cash. The question for investors isn't whether Stifel is healthy — it clearly is — but whether these new initiatives can finally move the revenue needle.

Risk Assessment

PRIMARY RISK: Revenue growth stagnation (-0.2% vs. industry +16.1%) is the single thesis-breaking scenario. If Q4 2026 revenue comes in flat or negative again, analyst EPS growth projections of 15.3% (next year) and 14.2% (5-year) will be revised downward, compressing both the earnings base and potentially the multiple. Mitigation: $4.92B cash and 0.24 D/E mean SF can maintain EPS growth via buybacks for 2-3 more quarters without top-line help — buying time for the KBW European expansion and Capital Solutions hires to contribute revenue. SECONDARY RISK: Price has already moved 7% since prior report — entering near $71 with a $79 analyst target means the upside is 10.7% to consensus vs. 8.4% downside to stop ($64.50), a narrower margin than 16 days ago. Mitigation: Intrinsic value at conservative 15x P/E (1.05 PEG) is ~$86-90/share, providing a wider range if the multiple re-rates from the current 12.37x. MACRO RISK: Capital markets firms face cyclical headwinds if deal activity slows — SF's mid-market focus could lag large-cap M&A recovery. Mitigation: conservative balance sheet allows SF to maintain operations and market share investment through the cycle. STOP LOGIC: $64.50 represents ~9.5% below entry ($70.25), aligning with technical support below the prior $66.68 level and providing a buffer against typical volatility before the next earnings catalyst.

Related Halal Stocks

Related Stocks

Frequently Asked Questions

Is SF a halal stock?

No, Stifel Financial Corp (SF) is currently not classified as halal by AAOIFI criteria.

What is Plutrex's AI rating for SF?

Stifel Financial Corp (SF) has a Plutrex AI rating of 76.0/100 with a Buy consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.

Is SF a good investment?

According to Plutrex AI, SF has a Buy rating (76.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.

How can I invest in SF?

US stocks like SF can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. ElBarake provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.

What are the main risks of investing in SF?

Plutrex AI identifies the main risks for SF by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.

Chat with ElBarake AI about SF

Ask anything about this stock and get an instant AI-powered answer — free, no signup required.

Open SF in ElBarake